NCT04409431View on ClinicalTrials.gov

Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

December 30, 2024

Study Completion Date

December 1, 2025

Conditions
Primary AldosteronismHypertension
Interventions
PROCEDURE

Endovascular chemical Ablation of Adrenal Gland

Patients in this group will be treated with partial ablation of adrenal gland by endovascular injection of dehydrated alcohol

Trial Locations (1)

400042

RECRUITING

The third hospital affiliated to the Army Medical University, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER